SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Liabilities | ₹333 Cr | ₹514 Cr | ₹830 Cr |
What is the latest Total Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹333 Cr |
| Mar2024 | ₹514 Cr |
| Mar2023 | ₹830 Cr |
How is Total Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹333 Cr | -35.14 | |
| Mar2024 | ₹514 Cr | -38.11 | |
| Mar2023 | ₹830 Cr | - | |
Compare Total Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,333.7 Cr | 2.7% | 1.2% | -30.7% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹25,782.1 Cr | -0.5% | -3.4% | -26% | Stock Analytics | |
| SAGILITY INDIA | ₹23,144.5 Cr | -3.1% | 3.9% | 66.6% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹9,992.3 Cr | 2.9% | 11.7% | 7.8% | Stock Analytics | |
| JUST DIAL | ₹6,369.4 Cr | -3.9% | -3.7% | -30.4% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹3,840.4 Cr | -3.7% | -12.6% | -18.4% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 2.7% |
1.2% |
-30.7% |
| SENSEX | -0.1% |
0.6% |
9.8% |
You may also like the below Video Courses